How the pore-forming protein perforin delivers apoptosis-inducing granzymes to the cytosol of target cells is uncertain. Perforin induces a transient Ca 2+ flux in the target cell, which triggers a process to repair the damaged cell membrane. As a consequence, both perforin and granzymes are endocytosed into enlarged endosomes called 'gigantosomes'. Here we show that perforin formed pores in the gigantosome membrane, allowing endosomal cargo, including granzymes, to be gradually released. After about 15 min, gigantosomes ruptured, releasing their remaining content. Thus, perforin delivers granzymes by a two-step process that involves first transient pores in the cell membrane that trigger the endocytosis of granzyme and perforin and then pore formation in endosomes to trigger cytosolic release.
A r t i c l e s
Cytotoxic T lymphocytes and natural killer (NK) cells eliminate virusinfected or malignantly transformed cells principally by releasing the contents of cytotoxic granules 1 into the immune synapse formed with their target cell [2] [3] [4] [5] . The granule serine proteases (granzymes) induce programmed cell death [6] [7] [8] after they are delivered into the target cell cytoplasm by the pore-forming granule protein perforin [9] [10] [11] [12] . Perforindeficient mice are profoundly immunodeficient. They fail to eliminate many viruses and other intracellular pathogens, spontaneously develop B cell lymphoma and are highly susceptible to carcinogeninduced neoplasia 13 . Humans bearing genetic mutations that lead to impaired synthesis, function or release of perforin develop familial hemophagocytic lymphohistiocytosis 14, 15 .
The way that perforin delivers granzymes to the cytosol of target cells is not fully understood 16 . Perforin binds in a Ca 2+ -dependent manner to membranes and multimerizes to form pores. Two models 17 , both based on the membranolytic properties of perforin 18 , differ in their predicted site of action. The simplest model is that granzymes are delivered directly to the cytosol by plasma membrane pores [19] [20] [21] [22] . Cells treated with high concentrations of recombinant or purified perforin form pores that are visible by electron microscopy and are sufficiently large for granzymes to pass through. However, perforin at such high concentrations forms stable pores that kill a cell by necrosis, whereas at physiological concentrations that deliver granzymes to induce apoptosis, granzymes are taken up with perforin into endosomes rather than being delivered directly to the cytosol, as would be predicted if they entered via plasma membrane pores 23, 24 . This scenario has prompted a revised model that suggests that perforin acts at the endosomal membrane by damaging its structural integrity (as originally proposed 25, 26 ), like some bacterial pore-forming proteins, to release granzymes to the cytosol.
At physiologically relevant, sublytic concentrations and during killer cell-mediated lysis, perforin perturbs the target plasma membrane (presumably by creating small pores in the target-cell membrane), transiently allowing Ca 2+ and small dyes to enter the target cell 23 . The Ca 2+ influx triggers the damaged membrane-repair response in which plasma membrane lesions are repaired via calcium-dependent exocytosis of lysosomes and other vesicles [27] [28] [29] . Another feature of the damaged-membrane response is the induction of endocytosis for the removal of the damaged membrane from the cell surface to preserve the integrity of the cell membrane 23, 24, 30 . Treatment of target cells with perforin and granzymes or killer cells leads to rapid clathrin-and dynamin-dependent endocytosis 24 . Greatly enlarged vesicles positive for early endosomal antigen 1 (EEA1) 23, 24 , called 'gigantosomes' , are formed that contain perforin and granzymes. When the cellular membrane-repair response is inhibited by Ca 2+ chelation or inhibitors of endocytosis, treated cells die by necrosis rather than by apoptosis, which suggests that activating the membrane-repair response is critical for immune response-mediated death by apoptosis.
The aim of our study here was to investigate how gigantosomes form and how granzymes are released from them. Using live-cell imaging microscopy, we found that gigantosomes formed in target cells by GTPase Rab5-dependent homotypic fusion between EEA1-stained early endosomes. However, endosomal fusion was not essential for cell death. Moreover, perforin-induced gigantosomes did not acidify.
We visualized granzyme B and perforin in cells subjected to attack by NK cells. By live-cell imaging, we found that granzyme-and perforincontaining gigantosomes formed not only when cells were treated with sublytic concentrations of perforin but also during cell-mediated cytolysis. Perforin-mediated release of cargo into the cytosol occurred about 10-15 min after perforin treatment, coincident with perforin multimerization in the gigantosome membrane. Cargo release gradually occurred from discrete locations in the endosomal membrane, followed by rupture of endosomes and release of their remaining cargo.
RESULTS

Apoptosis without gigantosome formation
We first verified that large EEA1 + intracellular vesicles (gigantosomes) that contained perforin and granzymes 23, 24 formed after treatment with sublytic concentrations of perforin 23, 24 (Supplementary Fig. 1a ).
These enlarged endosomes were negative for the lysosome marker CD107a (LAMP-1) and formed by homotypic fusion of early endosomes ( Supplementary Fig. 1b-e) . Rab5 is a small GTPase that regulates fusion between endocytic vesicles and early endosomes, as well as homotypic fusion between early endosomes [31] [32] [33] . Mutant Rab5 with substitution of asparagine for the serine at position 34 (Rab5(S34N)) has an affinity for GDP and acts as a dominant-negative inhibitor of Rab5 (ref. 34) . In HeLa human epithelial cells transfected with plasmids encoding EEA1 tagged with monomeric red fluorescent protein and wild-type Rab5 tagged with enhanced green fluorescent protein (eGFP), gigantosomes formed within 10 min of treatment of the cells with sublytic concentrations of perforin, but they did not form when wild-type Rab5 was replaced with Rab5(S34N) (Supplementary Fig. 2 ). Thus, gigantosome formation was Rab5 dependent. We next determined whether gigantosome formation is required for the induction A r t i c l e s of apoptosis by granzyme B and perforin. We assessed perforinand granzyme B-mediated apoptosis by cleavage of cytokeratin 18 and caspase-3 and staining with annexin V and propidium iodide in HeLa cells transfected with plasmid encoding wild-type Rab5 or Rab5(S34N) ( Fig. 1 and Supplementary Fig. 3 ). Apoptosis was similar in untransfected control cells and in cells expressing wild-type Rab5 or Rab5(S34N). Thus, gigantosome formation was dispensable for granzyme B-mediated induction of apoptosis.
Perforin inhibits early endosome acidification
Granzymes must be released into the target-cell cytosol to trigger apoptosis 23, 24 . We hypothesized that granzymes are released when perforin forms endosomal membrane pores. However, early endosomes normally rapidly acidify through the actions of the vacuolar ATPase 35 , and perforin pore formation is severely compromised at a pH below 6.5 (ref. 36 ; data not shown). We therefore predicted that perforin might interfere with endosomal acidification. We first assessed whether perforin-mediated delivery of granzyme B and induction of apoptosis required endosomal acidification by treating target cells with bafilomycin A1, an inhibitor of the vacuolartype H + -ATPase 37,38 ( Fig. 2a) or with ammonium chloride, a weak base that increases endosomal pH by unidirectional diffusion into endosomes 39 ( Fig. 2b) . Perforin-and granzyme B-mediated apoptosis was not altered by pretreatment of HeLa cells with these agents that interfere with endosomal acidification. Similarly, preincubation of target cells with bafilomycin A1 did not affect NK cell-mediated killing (Fig. 2c) . Moreover, pretreatment with bafilomycin A1 did not lead to more perforin-induced necrosis ( Supplementary Fig. 4a ). Therefore, delivery of granzyme B by perforin did not require endosomal acidification.
To assess whether perforin-containing gigantosomes acidify, which would interfere with pore formation by perforin in the gigantosome membrane, we treated cells with sublytic concentrations of perforin and with pHrodo dextran, which emits a bright red-fluorescent signal in an acidic environment. In cells treated with pHrodo dextran without perforin, endosomal red fluorescence increased over a few minutes, as expected. However, in cells treated with sublytic concentrations of perforin, red fluorescence in the gigantosomes progressively decreased with time ( Fig. 2d-f) . Within 10 min, most gigantosomes did not show any red fluorescence, unlike normal endosomes in the same cell or in cells not exposed to perforin (Fig. 2g) . Thus gigantosomes did not acidify like normal endosomes. The lack of gigantosome acidification may have been due to perforin pore formation in the gigantosome membrane, which would interfere with the maintenance of a pH gradient across the gigantosome membrane. To confirm the data above, we also co-treated cells with perforin and the ratiometric probe Lysosensor Yellow/Blue, which fluoresces in the green channel only at low pH. At the earliest times, Lysosensor Yellow/Blue fluorescence was similar in perforin-treated and control cells, which suggested that their dye uptake was equivalent (data not shown). However, cells treated with sublytic concentrations of perforin demonstrated a rapid progressive decrease in Lysosensor Yellow/Blue green fluorescence over 5 min, whereas the fluorescence in cells treated with medium did not change. Moreover, the lower fluorescence was not due to leakage of dye from the cell, as plasma membrane integrity, assessed by lack of uptake of propidium iodide, remained unimpaired ( Supplementary Fig. 4b ). Thus, gigantosomes that formed in perforintreated cells did not acidify.
Perforin forms pores in the endosomal membrane
The most likely explanation for perforin permeabilization of the gigantosome membrane was that perforin forms pores in the gigantosome membrane. We treated target cells with perforin and stained them 7 min later with the Pf-80 monoclonal antibody to human perforin, used before for visualization of perforin in target cell gigantosomes 24 ; this confirmed the localization of perforin in gigantosomes (Fig. 3a) . High-magnification images of gigantosomes stained with Pf-80 7 min after the addition of perforin showed highly localized perforin staining in clumps on the endosomal membrane ( Fig. 3b and Supplementary Fig. 5a,b) , as might be expected to form as perforin multimerizes to form pores. However, Pf-80 staining became almost completely undetectable 15 min after perforin was loaded. Pf-80 recognizes an epitope that is exposed in monomeric perforin and in the first step of the binding of perforin to membranes, but staining disappears when perforin multimerizes to form transmembrane pores 40 . The disappearance of perforin staining could be due either to the formation of perforin pores or to degradation of perforin in the target cell. However, staining of perforin with monoclonal antibody Pf-344, which recognizes an epitope that remains exposed throughout the various steps in perforin pore formation 40 , was still detectable even 15 min later (Fig. 3c,d and Supplementary  Fig. 5c ). Similarly, by flow cytometry, staining of perforin-treated cells with Pf-80 was visible 5 min after the addition of perforin but was no longer detectable at 10 or 15 min, whereas staining with Pf-344 persisted for as long as it was measured (15 min; Fig. 3e,f) . Therefore perforin was not degraded; instead, staining of perforin with Pf-80 disappeared because perforin formed pores in the gigantosome membrane. To confirm that finding, we next assessed whether we could detect perforin multimers in target cells with chemical crosslinking (Fig. 3g) . We incubated target cells for 1-15 min with a sublytic concentration of native human perforin before adding the membrane-permeable crosslinking agent disuccinimidyl suberate. Immunoblot analysis of perforin in the lysates of crosslinked cells showed a gradual decrease of the 60-kilodalton (60-kDa) perforin monomer, whereas two crosslinked bands appeared after 10 min and increased in intensity at 15 min. The lower band had an estimated size of ~420 kDa, consistent with the size of a perforin heptamer, and the top band migrated near the top of the gel, which suggested the formation of a much larger multimer. At these time points, perforin staining was almost exclusively present in endosomes 24 ( Fig. 3a,c) , which suggested that pore formation occurs in endosomal membranes. When we fractionated perforin-treated cells to isolate cytoplasmic vesicles before crosslinking with disuccinimidyl suberate, we also found crosslinked bands of the same size ( Supplementary  Fig. 5d ). Thus, perforin pore formation increases over time in the gigantosome membrane.
Release of granzyme B and other cargo from gigantosomes To test our hypothesis that perforin pore formation in the endosomal membrane is responsible for granzyme release, we co-stained for EEA1 and granzyme B and assessed the timing of granzyme B uptake and cytosolic release after treatment with perforin and granzyme B. In the absence of perforin, cells did not efficiently 
A r t i c l e s
We obtained similar results with cells transfected with monomeric red fluorescent protein-tagged EEA-1 and treated with dextran tagged with 10-kDa cationic rhodamine green and perforin (data not shown). After 10 min, we began to observe discrete and localized release of TR-dextran from gigantosomes into the cytosol, whereas the gigantosome membrane seemed to remain intact ( Fig. 5b and Supplementary Fig. 6a) . A little later (~15-17 min after loading of perforin-TR-dextran), the gigantosome membrane became unstable. EEA1 coating of gigantosomes disappeared and endosomal tubulations formed, which was followed by rupture of the gigantosome membrane, leading to complete release and diffusion of dextran into the cytosol (Fig. 5b,c, Supplementary Fig. 6b and Supplementary  Movies 1-3) . As dextran diffuses, it becomes difficult to detect. To confirm our impression that TR-dextran was released from gigantosomes into the cytosol before they ruptured, we imaged perforinand dextran-treated cells by live-cell four-dimensional spinning-disk confocal imaging beginning 7 min after the addition of perforin and dextran. We measured the staining intensity of TR-dextran in the gigantosome or endosomes and in their surrounding cytoplasm (Fig. 5d) . In the absence of perforin, the TR-dextran signal in endosomes gradually increased as more dextran was incorporated, but the signal in the surrounding cytosol remained low and was stable, with some fluctuation. However, in cells treated with perforin, the signal intensity of TR-dextran in the gigantosome gradually decreased as Texas red staining in the surrounding cytoplasm increased. As a take up granzyme B (Fig. 4a) . After exposure to sublytic concentrations of perforin and granzyme B, granzyme B-containing EEA1 + gigantosomes formed within 5 min. After ~10-15 min, granzyme B was released from gigantosomes to the cytosol, as the bright vesicular staining of the endocytosed cargo dispersed into a faintly detected haze in the cytosol. Within 20 min, most of the granzyme B signal was concentrated in the nucleus, as expected 41 , and we no longer detected gigantosomes (Fig. 4a,b) . We also noted uptake of Alexa Fluor 488-granzyme B into gigantosomes within 2 min of adding perforin. Cytosolic fluorescence began to be visible within 5 min, but by 15 min, gigantosome staining had disappeared and granzyme B became cytosolic and nuclear (Fig. 4c) . Therefore, the release of granzyme B from gigantosomes in perforin-treated cells within ~15 min coincided temporally with perforin pore formation, as judged by the disappearance of Pf-80 staining and perforin crosslinking.
Gigantosomes leak cargo and then rupture
We next used live-cell imaging to visualize the release of gigantosome cargo from perforin-treated cells. We used time-lapse spinning-disk confocal microscopy to image trafficking of the 10-kDa fluid-phase endocytosis marker Texas red-dextran (TR-dextran) in perforin-treated HeLa cells transfected to express eGFP-tagged EEA1. As described before 24 , perforin enhanced the endocytosis of TR-dextran, and TRdextran remained located in gigantosomes after 10 min (Fig. 5a) . A r t i c l e s control, we measured the background intensity of TR-dextran staining in a region of the cytosol that did not contain gigantosomes or endosomes and found that it did not change. Together these data suggest that perforin pores in the gigantosome membrane allow the slow release of endosomal cargo before completely destabilizing the endosomal membrane, which leads to endosomolysis and rapid release of the remaining cargo to the cytosol (model for perforin delivery of granzymes, Supplementary Fig. 7 ).
Release of granzyme B from gigantosomes during NK cell attack
The most physiologically relevant system with which to study the actions of perforin is lysis of target cells mediated by cytotoxic T lymphocytes or NK cells. However, no published studies have visualized trafficking of perforin or granzyme in cells subjected to killer cell-mediated destruction, presumably because the amount of native enzyme that enters a target cell is limited. We obtained the data presented above by incubating target cells with sublytic concentrations of perforin (with or without granzyme B), which is considered a good surrogate for killer cell-mediated cell death, as it reproduces the apoptotic features of the target cell. The two components of the cellular membrane-repair response (fusion of internal vesicles with the plasma membrane and rapid endocytosis of the damaged membrane) are present in cells targeted by CD8 + T cells and NK cells 23, 24 . Moreover, EEA1 + gigantosomes form in target cells during killer cell attack 23, 24 . To assess further whether the two-step model of the delivery of granzyme by perforin via endosomes applies to the physiologically most relevant model of killer cell attack, we incubated the human NK cell line YT-Indy with 721.221 human B cells (as target cells) and examined NK cell-target cell conjugates at various times over 20 min on slides stained for granzyme B or perforin. In NK cells, granzyme B and perforin stained in granules that concentrated at the interface with the target cell, as expected (Fig. 6a,b) . Although staining of granzyme B or perforin was not apparent in most target cells, at 10 min, we were able to visualize in a few cells granzyme B and perforin in enlarged cytosolic vesicles with a size like that of gigantosomes. Target cells with staining of granzyme B or perforin typically had one or a few gigantosomes visible near the killer celltarget cell interface. After 20 min of incubation, we detected dispersion of granzyme B in the cytosol of a few target cells. At the same time, we did not detect perforin staining with the conformation-sensitive antibody Pf-80 in any target cell (Fig. 6b) . To monitor granzyme B trafficking in target cells, we also imaged YT-Indy cells that expressed eGFP-granzyme B as they targeted 721.221 cells (Fig. 6c) . We found that eGFP-granzyme B first concentrated in a gigantosome-like structure that was visible within a minute of conjugate formation before dispersing in the cytosol ~10-17 min later. Therefore, endocytosis of granzyme B and perforin into gigantosomes and perforin-induced release of granzyme B from gigantosomes into the cytosol of target cells also occurred during attack by killer cells.
DISCUSSION
At physiologically relevant concentrations of perforin and during attack by cytotoxic T lymphocytes, perforin creates short-lived pores in the plasma membrane of the target cell. These pores cause a transient influx of Ca 2+ into the target cell that lasts a few hundred seconds and mobilizes the stereotypic cellular response to plasma membrane damage 23 . The membrane-repair response, which is triggered by an increase in intracellular Ca 2+ concentration, mends the damaged plasma membrane by the fusion of lysosomal and endosomal membranes 23, 30 and by endocytosis to remove the damaged membrane 24 .
The stimulation of endocytosis leads to the internalization of perforin and granzymes into early endosomes 24 . In cells treated with physiologically relevant, sublytic concentrations of perforin, we observed A r t i c l e s the formation of giant endosomes (gigantosomes) that contained perforin and granzymes. We also noted enlarged EEA1 + vesicles in target cells during attack by killer cells. A hallmark of the membrane-repair response is exuberant heterotypic and homotypic fusion caused by Ca 2+ -dependent activation of vesicular trafficking molecules, such as the synaptotagmins and SNARE proteins [27] [28] [29] . We found that gigantosomes formed by Rab5-dependent fusion of early endosomes. However, gigantosome formation was an extraneous phenomenon that did not contribute to killing of target cells. As target cells that did not form gigantosomes were equally susceptible to granzyme B and perforin, these results suggest that granzymes also escape from smaller granzyme-and perforin-containing endosomes via the action of perforin in endosomes. Although we saw granzymes in endosomes within a few minutes of exposure to perforin, granzymes were present in the cytosol only much later (~15 min after treatment). This result suggested that the pores formed by perforin in the plasma membrane were either too small or too rapidly removed to deliver granzymes directly to the cytosol. We next investigated how gigantosome cargo is delivered to the cytosol. We found that granzymes and other cargo were released into the cytosol through the action of perforin in the gigantosome membrane. Imaging of cells treated with perforin and granzymes showed perforin concentrated in discrete foci that formed on the gigantosome membrane, which suggested that perforin forms pores in the endosomal membrane. However, perforin pore formation does not occur at an acidic pH 36 . Here we found that unlike normal early endosomes 35 , gigantosomes did not acidify, thereby facilitating perforin pore formation in the gigantosome. The lack of acidification was probably secondary to perforin pore formation, which would interfere with the maintenance of a pH gradient across the gigantosome membrane and would lead to equilibration of the gigantosome pH with the neutral cytosolic pH. In further support of the proposal of perforin pore formation in the gigantosome membrane, staining of gigantosomes with the perforin antibody Pf-80, which recognizes an epitope obscured during pore formation 40 , disappeared. This lack of staining was not due to degradation of perforin, as staining with Pf-344, an antibody that recognizes both monomeric and multimerized perforin, persisted. Moreover, crosslinking studies showed that perforin assembled into larger complexes in gigantosomes over 15 min, coincident with the release of gigantosome cargo. Crosslinking analysis suggested that there might be two types of perforin pores: a smaller multimer made up of about seven perforin monomers, and a much larger multimer of indeterminate size. However, that finding needs to be confirmed by other methods. We imaged fluorescent cargo (fluorescence-labeled and unlabeled granzyme B and fluorescence-labeled dextran) as it was released from gigantosomes. Cargo was first released at a slow but steady rate beginning ~10 min after cells were exposed to perforin. After ~15 min, the endosomal membrane developed tubulations and eventually ruptured, which led to the complete release of cargo. Notably, treatment of cells with the vacuolar ATPase inhibitor bafilomycin A, which like perforin prevents endosomal acidification, also causes endosomal tubulations like those we visualized with perforin 42 . It is not clear what triggers the final rupture of the gigantosome or what proportion of granzyme B might be released via pores versus at the time of gigantosome lysis. The release of 10-kDa dextran, which we measured before rupture, may not exactly mimic what happens with 32-kDa granzyme B or the granzyme A dimer, which is twice as large. Given the results of live-cell imaging of perforin-treated cells, it is likely that most granzyme release occurs at the time of gigantosome rupture. Our images of granzyme B in NK cell-targeted cells also suggested that some granzyme B was released before gigantosome rupture, but the resolution of the images was not good enough to be certain.
In our studies of perforin loading of granzymes and killer cell lysis by staining of fixed cells or by videomicroscopy, we never saw evidence of the entry of granzyme directly into the cytosol via the plasma membrane. We therefore think this is unlikely. However, we cannot rule out the possibility that small amounts of granzymes entered through transient plasma membrane pores but were not detected because they diffused rapidly and the fluorescent signal was not concentrated enough to be detected above background. The response of damaged plasma membranes to bacterial pore-forming toxins and complement has been shown to include blebbing or exocytosis of damaged membranes 43, 44 in addition to the two phenomena we found in cells exposed to sublytic concentrations of perforin (patching by fusion of vesicular membranes and endocytosis of damaged membrane 23, 24 ). In some cells, blebbing of the plasma membrane is a prominent feature after treatment with sublytic concentrations of perforin and granzymes. Examination of culture supernatants of targeted cells for granzyme-and perforin-containing exosomes may indicate whether exocytosis of perforin-damaged membranes is prominent in some cells and promotes apoptotic cell death.
Our results suggest a two-step model for the delivery of granzymes by perforin in which perforin first forms transient pores in the targetcell plasma membrane that trigger the membrane-repair response, leading to the endocytosis of granzymes and perforin together. Perforin then forms larger, more stable pores in the endosomal membrane to trigger the release of granzymes. Although we used granzyme B in the experiments presented here, we obtained similar results when we studied granzyme A, the other main granzyme (data not shown). Therefore, we expect that this model applies to all granzymes. This model, which suggests that perforin can form at least two types of pores of different size and stability, is supported by a published study that measured conductance through various sorts of membranes (planar lipid bilayers and unilamellar vesicles of different lipid composition and size) treated with perforin 45 . There was a good deal of heterogeneity in perforin pores; in particular, the formation of small, highly unstable pores preceded the development of more stable and larger pores with a distribution in size. Heterogeneous pore formation was confirmed by cryoelectron microscopy. We therefore hypothesize that the rapid membranerepair response interferes with the formation of larger pores on the plasma membrane but that perforin multimerizes into larger stable pores on the gigantosome membrane that increase in size within 5-15 min of the addition of perforin. Given the kinetics of early endosome acidification, our data suggest that the smaller pores formed in the gigantosome membrane almost immediately to interfere with acidification and allow perforin to remain active.
Our evidence for replacing the old model of granzyme delivery through plasma membrane pores with a more complicated two-step model of perforin delivery is based mostly on experiments using treatment of target cells with perforin and granzyme at sublytic concentrations of perforin, which is considered a good model for cellmediated cytotoxicity. It could be argued, however, that what happens during attack by killer cells might be different. During perforin-and granzyme-loading experiments, the killer molecules are delivered across the plasma membrane, whereas in cell-mediated lysis, perforin and granzymes are delivered to a localized area of the target cell membrane in the immunosynapse. The repair of diffuse membrane damage might become more important in the former case than in the latter, when membrane damage is localized. Until now it has been impossible to visualize perforin and granzymes in target cells undergoing attack by killer cells, which has made it difficult to assess whether it is really necessary to revise the old plasma membrane pore model. EEA1 + gigantosomes do in fact form in the target cell during attack by cytotoxic T lymphocytes 23, 24 . Because of the improved imaging resolution of the highly sensitive spinning-disk confocal microscope, we were able to detect granzyme B and perforin in target cells as they were being killed. The killer molecules did in fact localize rapidly to giant endosomes that formed near the immune synapse before they were detected throughout the cytosol. Rather than the formation of multiple gigantosomes, as was seen in cells treated with perforin and granzyme B in solution, presumably in response to diffuse membrane damage, it is likely that only one gigantosome or a few gigantosomes form when the damage is localized to the immune synapse. The concentration of perforin and granzyme in gigantosomes in target cells followed by granzyme release during attack by killer cells suggests that the two-step model for the delivery of granzymes by perforin accurately reflects what happens in vivo.
METHODS
Methods and any associated references are available in the online version of the paper at http://www.nature.com/natureimmunology/.
